![Bryan Cox](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Cox
Directeur Technique/Scientifique/R&D chez
TRISALUS LIFE SCIENCES, INC.
Fortune : 363 936 $ au 31/05/2026
Profil
Bryan F.
Cox is currently Chief Executive Officer & Director at Nephraegis Therapeutics, Inc. since 2018 and Chief Research Officer at TriSalus Life Sciences, Inc. since 2020.
Formerly, Dr. Cox was Director-Integrative Pharmacology at Abbott Laboratories from 1996 to 2013.
Education includes a doctorate from the University of Iowa and an undergraduate degree from The University of North Carolina at Chapel Hill.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/03/2026 | 106 726 ( 0,17% ) | 363 936 $ | 31/05/2026 |
Postes actifs de Bryan Cox
| Sociétés | Poste | Début |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
Nephraegis Therapeutics, Inc.
 Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops kidney therapies | Directeur Général | 01/11/2018 |
Anciens postes connus de Bryan Cox
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2013 |
Formation de Bryan Cox
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nephraegis Therapeutics, Inc.
Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops kidney therapies | Health Technology |
TriSalus Life Sciences, Inc.
 TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
